Search for: "Abbott Laboratories, Inc." Results 81 - 100 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Dec 2015, 5:58 am by Mary Jane Wilmoth
Nation’s Second-Largest Nursing Home Pharmacy to Pay $9.25 Million to Settle Kickback Allegations The nation’s second-largest nursing home pharmacy, PharMerica Corp., has agreed to pay $9.25 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug Depakote for nursing home patients. [read post]
8 Dec 2015, 2:22 pm by Ben Vernia
  And in another settlement, PharMerica Corp., the nation’s second largest nursing home pharmacy, agreed to pay the United States $9.25 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the drug Depakote for nursing home patients. [read post]
9 Nov 2015, 4:00 am by Alan Macek
If the Canadian patent office requires that a divisional application be filed pursuant to Section 36(2.1) of the Patent Act, a court has held that it would “be unfair and inequitable” (see Abbott Laboratories v. [read post]
6 Oct 2015, 11:50 pm by Greene LLP
The allegations had accused PharMerica of taking kickbacks from Abbott Laboratories Inc. in order to increase the use of the seizure prevention drug Depakote with the patients in their nursing homes. [read post]
15 Sep 2015, 6:17 pm
Abbott Laboratories, Inc., No. 1:13-cv-144, slip op. [read post]
7 Sep 2015, 8:09 am by Gregory J. Brod
According to the article and assorted legal actions against the companies, drug companies including Abbott Laboratories and Amgen, Inc. paid millions of dollars in kickbacks and other financial incentives to encourage distributing pharmacies to push certain medications. [read post]
15 May 2015, 4:25 pm by Altman & Altman
The number of drug injury lawsuits against Pfizer Inc. over its Lipitor medication continues to rise. [read post]
13 Jan 2015, 8:17 am by Ronald V. Miller, Jr.
Manufactured by AbbVie Inc., a drugmaker that spun off Abbott Laboratories in 2013, Androgel has 60% of the testosterone replacement therapy market. [read post]
5 Dec 2014, 9:00 am
  The Seventh Circuit weighed in on the defense side under similar circumstances in In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012), which we commented on here. [read post]
The Eighth Circuit found that the dicta In re Abbott Laboratories, Inc., 698 F.3d  568 (7th Cir. 2012) applied to this case. [read post]
15 Sep 2014, 2:30 pm by Steven Koprince
 However, the DHA concluded that ADCSC could properly hold itself out as having an FSS contract because ADSCS’s affiliate, Abbott Laboratories, Inc., held such a contract. [read post]